Laboratory profiling of patients with long COVID in the Brazilian Amazon region: A cross‐sectional study
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29828 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Vanessa Costa Alves Galúcio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Biological Health Sciences, State University of Pará (UEPA), Belém, Brazil. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Amazon Foundation for Research Support (FAPESPA), Secretary of Science, Technology, and Higher, Professional and Technological Education (SECTET), Coordination for the Improvement of Higher Education Personnel-Brazil (CAPES).
Abstract (Originalsprache)
The condition commonly referred to as long coronavirus disease (COVID) is characterized by the continuation of symptoms, sometimes accompanied by new symptoms that persist after the resolution of acute coronavirus disease 2019 (COVID‐19). This observational cross‐sectional study investigated 332 patients with long COVID in the Brazilian Amazon region. The study aimed to elucidate the systemic interactions associated with long COVID by compiling the findings related to hematological, coagulation, immunological, metabolic, hepatic, renal, and muscular profiles. Participants with long COVID were identified using rigorous criteria and underwent thorough laboratory examinations. The obtained data were subsequently analyzed, allowing for comparisons, associations, and correlations between findings within distinct groups in the study. Significant associations were observed between hospitalization during the acute phase and persistent laboratory abnormalities, suggesting a potential link between acute severity and long‐term effects. Notably, individuals with long COVID for over a year exhibited elevated levels of monocytes, prolonged prothrombin times, reduced prothrombin activity, high levels of lactate dehydrogenase, and an increased frequency of qualitative C‐reactive protein detection. This study provides valuable insights into the laboratory risk profile of patients with long COVID, particularly in the unique context of the Amazon region, where patients exhibit persistent symptoms lasting up to 1261 days.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Biological Health Sciences, State University of Pará (UEPA), Belém, Brazil.
- School of Medicine, São Paulo University (USP), São Paulo, Brazil.
- Tropical Medicine Centre, Federal University of Pará (UFPA), Belém, Brazil.
Förderung
- Amazon Foundation for Research Support (FAPESPA)
- Secretary of Science, Technology, and Higher, Professional and Technological Education (SECTET)
- Coordination for the Improvement of Higher Education Personnel-Brazil (CAPES)
- National Council for Scientific and Technological Development-Brazil (CNPq)
Zitieren
APA
Galúcio, V. C. A., de Menezes, D. C., Chaves, E. C. R., van den Berg, A. V. S., de Lima, P. D. L., da Costa Vasconcelos, P. F., Quaresma, J. A. S., & Falcão, L. F. M. (2024). Laboratory profiling of patients with long COVID in the Brazilian Amazon region: A cross‐sectional study. Journal of Medical Virology. https://doi.org/10.1002/jmv.29828
Vancouver
Galúcio VCA, de Menezes DC, Chaves ECR, van den Berg AVS, de Lima PDL, da Costa Vasconcelos PF, et al. Laboratory profiling of patients with long COVID in the Brazilian Amazon region: A cross‐sectional study. Journal of Medical Virology. 2024. doi:10.1002/jmv.29828
BibTeX
@article{Galcio2024,
author = {Galúcio, Vanessa Costa Alves and de Menezes, Daniel Carvalho and Chaves, Elem Cristina Rodrigues and van den Berg, Ana Virgínia Soares and de Lima, Patrícia Danielle Lima and da Costa Vasconcelos, Pedro Fernando and Quaresma, Juarez Antônio Simões and Falcão, Luiz Fábio Magno},
title = {Laboratory profiling of patients with long COVID in the Brazilian Amazon region: A cross‐sectional study},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29828}
}
EUVIMED